COMPUTATIONAL BIOLOGY MARKET ANALYSIS

Computational Biology Market, By Type (Cellular and Biological Simulation (Computational Genomics, Computational Proteomics, Pharmacogenomics, and Others (Transcriptomics/Metabolomic)), Disease Modeling and Simulation Applications (Drug Discovery, Drug Development)), By Tools (Content/Database, Analysis Software and Services, and IT Infrastructure (Hardware)),and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jul 2023
Code : CMI3915
Pages :160
Formats :
Excel and PDF
Industry : Healthcare IT

Regional Analysis

Global Computational Biology Market - Regional Analysis

Among region, North America is estimated to hold a dominant position in the global computational biology market over the forecast period, owing to increasing clinical trials using computational biology tools of different formulations. For instance, on January 5, 2021, AsclepiX Therapeutics, Inc., U.S.-based biotechnology company, announced that the first patient was given a dose in phase 1/2a CONGO clinical trial to evaluate safety and bioactivity of AXT107 in patients with Diabetic Macular Edema. AXT107 is an investigational drug candidate that inhibits VEGF-A and VEGF-C and activates Tie2. AsclepiX Therapeutics, Inc. used computational biology to identify potent peptide regulators of vascular and cellular homeostatis.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa